Schedule 13G ownership disclosure

JASPER THERAPEUTICS INC

Common Stock, $0.001 Par Value · CUSIP: 471871202

Event date: 2025-12-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ACORN BIOVENTURES, L.P.

    Shares: 750,326.00 · Class: 2.7%

  • ACORN CAPITAL ADVISORS GP, LLC

    Shares: 750,326.00 · Class: 2.7%

  • ACORN BIOVENTURES 2, L.P.

    Shares: 1,036,166.00 · Class: 3.7%

  • Acorn Capital Advisors GP 2, LLC

    Shares: 1,036,166.00 · Class: 3.7%

  • Anders Hove

    Shares: 1,786,492.00 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001636587-25-000064
Form type
SCHEDULE 13G
Filer
ACORN BIOVENTURES, L.P.
CIK
CIK 1766853
Filed
Dec 02, 2025
Reporting period
Dec 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub